drugset / Trial / NCT01315327

Omega-3 Fatty Acids in Tourette's Disorder

NCT01315327 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.

Timeline

Start
2003-05
Primary completion
2006-02
Completion
2012-05

Outcome

Missed primary endpoint

paper subjects treated with O3FA did not have significantly higher response rates or lower mean scores on the YGTSS-Tic PMID 22585765 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown 6000 mg —

Indications